Clinical Trial Update: Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial of Tenofovir antiviral therapy following transarterial chemoembolization for HBV-related hepatocellular carcinoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatocellular Carcinoma

Drugs mentioned

• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: Taichung Veterans General Hospital | Conditions: Chronic Hepatitis B, Hepatocellular Carcinoma | Phase 3 | Status: TERMINATED